Heart valves: St. Jude Medical reports 1st transapical TAVI patient

November 26, 2012 by MassDevice staff

Medical device company St. Jude Medical reports the 1st implantation of its Portico heart valve via transapical delivery through the heart's left ventrical.

St. Jude Medical's Portico TAVI device

St. Jude Medical (NYSE:STJ) reported a milestone for its Portico heart valve today, saying the 1st patient was given the transcatheter aortic valve implant via a catheter threaded through an incision in the apex of the heart's left ventricle.

TAVI devices, used to treat aortic stenosis, are typically delivered via the femoral artery in the leg.

"The first patient implanted with the transapical delivery approach represents a significant milestone in our ongoing efforts to provide physicians a wide range of options to best treat their patients, "Frank Callaghan, president of St. Jude's cardiovascular & ablation technologies arm, said in prepared remarks.

Sign up to get our free newsletters delivered straight to your inbox

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp